CRITICAL ANALYSIS OF THE “REGIONAL HEALTH TECHNOLOGY ASSESSMENT REPORT ON THE IMPLICATIONS OF BEVACIZUMAB USE IN ADULT PATIENTS WITH METASTATIC COLORECTAL CANCER (DIME, 2015)”

OBJECTIVES: Analyze the results obtained in DIME-BID HTA for the treatment of metastatic colorectal cancer (mCRC). METHODS: a methodological analysis of the HTA presented by the DIME was performed. Focused on three parameters (research question, hypothesis, evidence and economic analysis). RESULTS:...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health 2017-05, Vol.20 (5), p.A125
1. Verfasser:	Briceno, V
Format:	Artikel
Sprache:	eng
Schlagworte:	Adults Bevacizumab Chemotherapy Clinical research Clinical trials Colorectal cancer Colorectal carcinoma Dominance Drug use Economic analysis Efficacy Health economics Immunotherapy Medical technology Metastases Minimization Monoclonal antibodies Patients Scientific evidence Targeted cancer therapy Technology assessment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!